Sign In
Buy SNY
$44.38
+2.01 (+4.74%)
At Close: Jun 04, 2026
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal
01:20pm, Friday, 10'th May 2024
Novavax shares soared after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Madison Muller reports on Bloomberg Televi
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi
12:24pm, Friday, 10'th May 2024
Novavax, Inc. (NASDAQ:NVAX) shares surged Friday following the announcement of a significant licensing agreement with Sanofi SA (ADR) (NYSE:SNY), valued at $1.2 billion. The deal encompasses the comme
Novavax (NVAX) Deal with Sanofi to Co-Commercialize Covid Vaccine
12:14pm, Friday, 10'th May 2024
Novavax (NVAX) signed a deal with drugmaker Sanofi to co-commercialize the Covid Vaccine. Diane King Hall discusses this, as well as Novavax's 1Q earnings.
Novavax stock soars on $1.2 billion Sanofi vaccine deal
11:58am, Friday, 10'th May 2024
Novavax (NVAX) shares are skyrocketing after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu shot. Yahoo Finance's Anjalee Khemlani joins The Morning Brie
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
10:45am, Friday, 10'th May 2024
Novavax (NVAX) shares more than doubled in intraday trading Friday after announcing a $1.2 billion deal to license its vaccine technology to French drugmaker Sanofi (SNY).
Vaccine Stock Explodes After Sanofi Deal
10:07am, Friday, 10'th May 2024
Novavax Inc (NASDAQ:NVAX) stock is up 130% to trade at $10.82 today, by far the best stock on the Nasdaq this morning.
Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps.
06:47am, Friday, 10'th May 2024
The two companies will also work on a shot that combines Covid-19 and flu vaccines.
3 Biotech Stocks to Sell in May Before They Crash & Burn
06:30am, Friday, 10'th May 2024
Although 5% up over one year, the S&P Biotechnology Select Industry Index is down .22% year-to-date. This seems to be a normalization period.
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses
05:53am, Friday, 10'th May 2024
Novavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the company's fiscal Q1 2024 earnings report but more significantly, by a crucial multi-billion dollar deal wi
Novavax shares surge on new $1.4 billion deal with Sanofi
05:00am, Friday, 10'th May 2024
Novavax on Friday said it had struck a $1.4 billion deal with Sanofi to commercialize its existing COVID-19 vaccine and develop a new combined jab to inoculate against both the coronavirus and influen
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
02:15am, Friday, 10'th May 2024
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's
France's Sanofi in COVID-19 vaccine deal with Novavax - statement
02:13am, Friday, 10'th May 2024
Sanofi on Friday announced it has reached a 'co-exclusive' licensing agreement with Novavax to sell a stand-alone COVID-19 vaccine and develop new flu-COVID-19 combination vaccines.
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
02:00am, Friday, 10'th May 2024
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial doubt" about its ability to survive.
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
12:21pm, Thursday, 25'th Apr 2024
Sanofi (SNY) posts first-quarter 2024 results and maintains the earnings growth guidance for the year.
Sanofi (SNY) Q1 2024 Earnings Call Transcript
11:24am, Thursday, 25'th Apr 2024
Sanofi (NASDAQ:SNY ) Q1 2024 Earnings Conference Call April 25, 2024 8:30 AM ET Company Participants Paul Hudson - Chief Executive Officer François-Xavier Roger - Chief Financial Officer Houman Ashra
